SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Colorado Yohar Sandra Milena)
 

Search: WFRF:(Colorado Yohar Sandra Milena) > (2023) > Prospective and Men...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Nimptsch, KatharinaMolecular Epidemiology Research Group, Max Delbrück Center for Molecular Medicine (MDC), Berlin, Germany (author)

Prospective and Mendelian randomization analyses on the association of circulating fatty acid binding protein 4 (FABP-4) and risk of colorectal cancer

  • Article/chapterEnglish2023

Publisher, publication year, extent ...

  • BioMed Central (BMC),2023
  • electronicrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:umu-215878
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-215878URI
  • https://doi.org/10.1186/s12916-023-03104-1DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Background: Fatty acid binding protein 4 (FABP-4) is a lipid-binding adipokine upregulated in obesity, which may facilitate fatty acid supply for tumor growth and promote insulin resistance and inflammation and may thus play a role in colorectal cancer (CRC) development. We aimed to investigate the association between circulating FABP-4 and CRC and to assess potential causality using a Mendelian randomization (MR) approach.Methods: The association between pre-diagnostic plasma measurements of FABP-4 and CRC risk was investigated in a nested case-control study in 1324 CRC cases and the same number of matched controls within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. A two-sample Mendelian randomization study was conducted based on three genetic variants (1 cis, 2 trans) associated with circulating FABP-4 identified in a published genome-wide association study (discovery n = 20,436) and data from 58,131 CRC cases and 67,347 controls in the Genetics and Epidemiology of Colorectal Cancer Consortium, Colorectal Cancer Transdisciplinary Study, and Colon Cancer Family Registry.Results: In conditional logistic regression models adjusted for potential confounders including body size, the estimated relative risk, RR (95% confidence interval, CI) per one standard deviation, SD (8.9 ng/mL) higher FABP-4 concentration was 1.01 (0.92, 1.12) overall, 0.95 (0.80, 1.13) in men and 1.09 (0.95, 1.25) in women. Genetically determined higher FABP-4 was not associated with colorectal cancer risk (RR per FABP-4 SD was 1.10 (0.95, 1.27) overall, 1.03 (0.84, 1.26) in men and 1.21 (0.98, 1.48) in women). However, in a cis-MR approach, a statistically significant association was observed in women (RR 1.56, 1.09, 2.23) but not overall (RR 1.23, 0.97, 1.57) or in men (0.99, 0.71, 1.37).Conclusions: Taken together, these analyses provide no support for a causal role of circulating FABP-4 in the development of CRC, although the cis-MR provides some evidence for a positive association in women, which may deserve to be investigated further.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Aleksandrova, KrasimiraDepartment Epidemiological Methods and Etiological Research, Leibniz Institute for Prevention Research and Epidemiology, Bremen, Germany; Faculty of Human and Health Sciences, University of Bremen, Bremen, Germany (author)
  • Pham, Thu ThiMolecular Epidemiology Research Group, Max Delbrück Center for Molecular Medicine (MDC), Berlin, Germany; Charité - Universitaetsmedizin Berlin, Corporate Member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, Berlin, Germany (author)
  • Papadimitriou, NikosNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France (author)
  • Janke, JürgenMolecular Epidemiology Research Group, Max Delbrück Center for Molecular Medicine (MDC), Berlin, Germany; Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Biobank Technology Platform, Berlin, Germany (author)
  • Christakoudi, SofiaDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom; Department of Inflammation Biology, School of Immunology and Microbial Sciences, King’s College London, London, United Kingdom (author)
  • Heath, AliciaDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom (author)
  • Olsen, AnjaDanish Cancer Society Research Center, Copenhagen, Denmark; Department of Public Health, University of Århus, Århus, Denmark (author)
  • Tjønneland, AnneDanish Cancer Society Research Center, Copenhagen, Denmark; Department of Public Health, University of Copenhagen, Copenhagen, Denmark (author)
  • Schulze, Matthias B.Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nutehtal, Germany; Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany (author)
  • Katzke, VerenaDepartment of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (author)
  • Kaaks, RudolfDepartment of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (author)
  • van Guelpen, BethanyUmeå universitet,Wallenberg centrum för molekylär medicin vid Umeå universitet (WCMM),Onkologi(Swepub:umu)beyvan99 (author)
  • Harbs, JustinUmeå universitet,Onkologi(Swepub:umu)juha0033 (author)
  • Palli, DomenicoCancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy (author)
  • Macciotta, AlessandraDepartment of Clinical and Biological Sciences, University of Turin, Turin, Italy (author)
  • Pasanisi, FabrizioDipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy (author)
  • Yohar, Sandra Milena ColoradoDepartment of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Research Group on Demography and Health, National Faculty of Public Health, University of Antioquia, Medellín, Colombia (author)
  • Guevara, MarcelaCIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Instituto de Salud Pública de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain (author)
  • Amiano, PilarCIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Ministry of Health of the Basque Government, Sub Directorate for Public Health and Addictions of Gipuzkoa, San Sebastian, Spain; Epidemiology of Chronic and Communicable Diseases Group, Biodonostia Health Research Institute, San Sebastián, Spain (author)
  • Grioni, SaraEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy (author)
  • Jakszyn, Paula GabrielaUnit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain; Blanquerna School of Health Sciences, Ramon Llull University, Barcelona, Spain (author)
  • Figueiredo, Jane C.Cedars-Sinai Medical Center Samuel Oschin Comprehensive Cancer Institute, CA, Los Angeles, United States (author)
  • Samadder, N. JewelDivision of Gastroenterology and Hepatology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, AZ, Phoenix, United States (author)
  • Li, Christopher I.Public Health Sciences Division, Fred Hutchinson Cancer Center, WA, Seattle, United States (author)
  • Moreno, VictorCIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Oncology Data Analytics Program, Catalan Institute of Oncology-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain; Department of Clinical Sciences, Faculty of Medicine and Health Sciences and Universitat de Barcelona Institute of Complex Systems (UBICS), University of Barcelona (UB), L’Hospitalet de Llobregat, Barcelona, Spain (author)
  • Potter, John D.Public Health Sciences Division, Fred Hutchinson Cancer Center, WA, Seattle, United States; Research Centre for Hauora and Health, Massey University, Wellington, New Zealand (author)
  • Schoen, Robert E.Department of Medicine and Epidemiology, University of Pittsburgh Medical Center, PA, Pittsburgh, United States (author)
  • Um, Caroline Y.Department of Population Science, American Cancer Society, GA, Atlanta, United States (author)
  • Weiderpass, ElisabeteInternational Agency for Research on Cancer, World Health Organization, Lyon, France (author)
  • Jenab, MazdaNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France (author)
  • Gunter, Marc J.Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France (author)
  • Pischon, TobiasMolecular Epidemiology Research Group, Max Delbrück Center for Molecular Medicine (MDC), Berlin, Germany; Charité - Universitaetsmedizin Berlin, Corporate Member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, Berlin, Germany; Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Biobank Technology Platform, Berlin, Germany (author)
  • Molecular Epidemiology Research Group, Max Delbrück Center for Molecular Medicine (MDC), Berlin, GermanyDepartment Epidemiological Methods and Etiological Research, Leibniz Institute for Prevention Research and Epidemiology, Bremen, Germany; Faculty of Human and Health Sciences, University of Bremen, Bremen, Germany (creator_code:org_t)

Related titles

  • In:BMC Medicine: BioMed Central (BMC)21:11741-7015

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view